Aveanna Q4 revenue rose 27.4% to USD 662.5 million as adjusted EBITDA climbed 54% to USD 85 million

Reuters

Mar 19

Aveanna Q4 revenue rose 27.4% to USD 662.5 million as adjusted EBITDA climbed 54% to USD 85 million

Aveanna filed a Form 8-K reporting Q4 and FY 2025 results.
Q4 revenue rose 27.4% to USD 662.5 million, driven by higher revenue in the Private Duty Services, Home Health & Hospice, and Medical Solutions segments.
Q4 net income was USD 178.8 million and Q4 adjusted EBITDA increased 54% to USD 85 million.
FY revenue increased 20.2% to USD 2.43 billion, while FY adjusted EBITDA rose 74.8% to USD 320.9 million.
Guidance for FY 2026 was maintained at revenue of USD 2.54-2.56 billion and adjusted EBITDA of USD 318-322 million, and Jeff Shaner said momentum across all three divisions supported the Q4 performance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aveanna Healthcare Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-115114), on March 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2620339244"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620339244\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620339244?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620339244","market":"nz","top_or_hot":-1,"title":"Aveanna Q4 revenue rose 27.4% to USD 662.5 million as adjusted EBITDA climbed 54% to USD 85 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Aveanna Q4 revenue rose 27.4% to USD 662.5 million as adjusted EBITDA climbed 54% to USD 85 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Aveanna filed a Form 8-<a href=\"https://laohu8.com/S/TKKD.SI\">K</a> reporting Q4 and FY 2025 results.\n        </li>\n<li>\n          Q4 revenue rose 27.4% to USD 662.5 million, driven by higher revenue in the Private Duty Services, Home Health &amp; Hospice, and Medical Solutions segments.\n        </li>\n<li>\n          Q4 net income was USD 178.8 million and Q4 adjusted EBITDA increased 54% to USD 85 million.\n        </li>\n<li>\n          FY revenue increased 20.2% to USD 2.43 billion, while FY adjusted EBITDA rose 74.8% to USD 320.9 million.\n        </li>\n<li>\n          Guidance for FY 2026 was maintained at revenue of USD 2.54-2.56 billion and adjusted EBITDA of USD 318-322 million, and Jeff Shaner said momentum across all three divisions supported the Q4 performance.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/AVAH\">Aveanna Healthcare Holdings Inc.</a> published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-115114), on March 19, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aveanna Q4 revenue rose 27.4% to USD 662.5 million as adjusted EBITDA climbed 54% to USD 85 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAveanna Q4 revenue rose 27.4% to USD 662.5 million as adjusted EBITDA climbed 54% to USD 85 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-19 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Aveanna Q4 revenue rose 27.4% to USD 662.5 million as adjusted EBITDA climbed 54% to USD 85 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Aveanna filed a Form 8-<a href=\"https://laohu8.com/S/TKKD.SI\">K</a> reporting Q4 and FY 2025 results.\n        </li>\n<li>\n          Q4 revenue rose 27.4% to USD 662.5 million, driven by higher revenue in the Private Duty Services, Home Health &amp; Hospice, and Medical Solutions segments.\n        </li>\n<li>\n          Q4 net income was USD 178.8 million and Q4 adjusted EBITDA increased 54% to USD 85 million.\n        </li>\n<li>\n          FY revenue increased 20.2% to USD 2.43 billion, while FY adjusted EBITDA rose 74.8% to USD 320.9 million.\n        </li>\n<li>\n          Guidance for FY 2026 was maintained at revenue of USD 2.54-2.56 billion and adjusted EBITDA of USD 318-322 million, and Jeff Shaner said momentum across all three divisions supported the Q4 performance.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/AVAH\">Aveanna Healthcare Holdings Inc.</a> published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-115114), on March 19, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL8L3nVk:1","article_id":"2620339244","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620339244","pubTimestamp":1773918124,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Aveanna filed a Form 8-K reporting Q4 and FY 2025 results.Q4 revenue rose 27.4% to USD 662.5 million, driven by higher revenue in the Private Duty Services, Home Health & Hospice, and Medical Solutions segments.Q4 net income was USD 178.8 million and Q4 adjusted EBITDA increased 54% to USD 85 million.FY revenue increased 20.2% to USD 2.43 billion, while FY adjusted EBITDA rose 74.8% to USD 320.9 million.Guidance for FY 2026 was maintained at revenue of USD 2.54-2.56 billion and adjusted EBITDA of USD 318-322 million, and Jeff Shaner said momentum across all three divisions supported the Q4 performance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aveanna Healthcare Holdings Inc. published the original content used to generate this ne","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","AVAH":"Aveanna Healthcare Holdings Inc.","BK4196":"保健护理服务"},"translate_title":"Aveanna第四季度收入增长27.4%至6.625亿美元，调整后EBITDA增长54%至8500万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVAH":0.9},"content_text":"Aveanna Q4 revenue rose 27.4% to USD 662.5 million as adjusted EBITDA climbed 54% to USD 85 million\n    \n\n\n          Aveanna filed a Form 8-K reporting Q4 and FY 2025 results.\n        \n\n          Q4 revenue rose 27.4% to USD 662.5 million, driven by higher revenue in the Private Duty Services, Home Health & Hospice, and Medical Solutions segments.\n        \n\n          Q4 net income was USD 178.8 million and Q4 adjusted EBITDA increased 54% to USD 85 million.\n        \n\n          FY revenue increased 20.2% to USD 2.43 billion, while FY adjusted EBITDA rose 74.8% to USD 320.9 million.\n        \n\n          Guidance for FY 2026 was maintained at revenue of USD 2.54-2.56 billion and adjusted EBITDA of USD 318-322 million, and Jeff Shaner said momentum across all three divisions supported the Q4 performance.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aveanna Healthcare Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-115114), on March 19, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}